Mednet Logo
CommunityRadiation Oncology

How do you approach management of a patient with intermediate risk prostate cancer treated upfront with HIFU and intermittent ADT who is later found to have rising PSA and biopsy-proven prostate-confined recurrence?

Is this considered salvage or definitive since HIFU is not standard of care? Does receipt of upfront HIFU impact ability to perform standard curative treatments?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Utah School of Medicine
Answered on

These are frustrating situations, and ones I am now seeing frequently as focal therapies have gained traction in the United States. The approach, needless to say, is highly individualized. Often, these glands are quite abnormal in MRI appearance, and there is a concern for fibrosis. My approach is h...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Texas MD Anderson Cancer Center
Answered on

I would treat him as a salvage as he has had treatment to his prostate gland. I would make sure that he does not have any evidence of lymph node/metastatic disease with an MRI scan of the pelvis and possibly a PSMA PET-CT scan.

For the treatment, I would recommend that the patient be treated with e...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

RT if it’s local and or regional. Plus ADT, depending on path and extent.

Join for free or sign in to see the full answer